What is Cibus, Inc.'s market cap?

Cibus, Inc. (CBUS) has a market capitalization of $128.4M and trades on NASDAQ.

Who are Cibus, Inc.'s competitors?

Cibus, Inc.'s key competitors include Corteva Agriscience, Ligand Pharmaceuticals Inc., DSS, Inc., and others. These companies compete in similar markets and product categories.

Where is Cibus, Inc. headquartered?

Cibus, Inc. is headquartered in United States of America and employs approximately 183 people. It has been publicly traded since 2017.

Cibus, Inc. (CBUS) Stock Fundamentals & Financials

Cibus is an agricultural biotechnology company specializing in the development of plant traits through proprietary gene editing technologies.

Market cap

$128.4M+85.1%

Earnings

Q2 2026 report

August 13, 2026

Revenue$994.0KMiss by $710.0K EPS-$0.29Miss by $0.10

Read the full report

Next report

Nov 12, 2026 (in 2 months)

Revenue estimate$1.3M

EPS estimate-$0.20

Competitors

By market cap

Corteva$55.3B+8.5%

Ligand Pharmaceuticals$5.7B+85.0%

Cibus, Inc.$128.4M+85.1%

DSS

DSS$5.4M-65.8%

Arcadia Biosciences$1.2M-76.4%

By revenue growth

Ligand Pharmaceuticals+54.9%

Corteva+5.0%

By net margin

Ligand Pharmaceuticals67.88%+108pp

Corteva9.42%+5.7pp

Profile

Cibus is an agricultural biotechnology company specializing in the development of plant traits through proprietary gene editing technologies. The company utilizes its time-bound platform to create specific genetic characteristics that improve crop productivity, sustainability, and environmental resilience. Its core value proposition lies in accelerating the speed of plant breeding to deliver novel traits that can be integrated into elite seed genetics.

Competitive position

A leader in non-GMO gene editing for agriculture, leveraging a proprietary platform to reduce the time required for trait integration into elite germplasm.

GeographiesUnited States, Latin America, India, Asia

Customer segmentsSeed producers, Global agricultural enterprises

Business modelIP Licensing, Royalty-based, Research and Development

SuppliersGenetic sequencing data, Laboratory equipment, Regulatory frameworks for gene editing

CustomersCommercial seed companies, Farmers, Agricultural distributors

CountryUnited States of America

Listed2017

Employees183.0

CEOCraig Wichner

SectorHealthcare

IndustryBiotechnology

Websitecibus.com

FilingsSEC EDGAR

FAQ

What is Cibus, Inc.'s market cap?: Cibus, Inc. (CBUS) has a market capitalization of $128.4M and trades on NASDAQ.
Who are Cibus, Inc.'s competitors?: Cibus, Inc.'s key competitors include Corteva Agriscience, Ligand Pharmaceuticals Inc., DSS, Inc., and others. These companies compete in similar markets and product categories.
Where is Cibus, Inc. headquartered?: Cibus, Inc. is headquartered in United States of America and employs approximately 183 people. It has been publicly traded since 2017.